home.aspx
home.aspx
 
. http://www.legalbusiness.co.uk/index.php/lb-blog-view/8557-latham-acts-for-baxter-on-latest-pharma-acquisition-as-hsf-picks-up-new-client-claris
blog article
LATHAM ACTS FOR BAXTER ON LATEST PHARMA ACQUISITION AS HSF PICKS UP NEW CLIENT CLARIS
Herbert Smith Freehills (HSF) and Latham & Watkins won lead roles on Baxter International's acquisition of Claris Injectables for $625m, in a bid by Baxter to expand its portfolio of essential generic injectable medicines. HSF represented Claris, while Latham acted for Baxter. Baxter manufactures a broad range of essential generic injectable medications while Claris is based in India and has a 15 year history in the global injectables market. The acquisition is expected to deliver annual global revenues in excess of $100m. READ MORE